Archive · 11 Jan 2026
World's First Weight-Loss Pill Launched
A company called Novo Nordisk has made the world's first weight-loss pill called Wegovy.
It's much cheaper than other weight-loss treatments that you have to inject.
The pill works by making you feel less hungry.
Novo Nordisk hopes this will help them sell more of their product and catch up to their competitors.
Other companies are also working on similar pills, so there might be a price war.
The pill is now available in the US for about $149 a month.
Some people think this could be a big deal for helping people lose weight, but others are worried about the cost and competition.
Novo Nordisk launched the world's first weight-loss pill, Wegovy, in the US for $149 per month (starting dose).
The pill mimics the GLP-1 hormone to reduce appetite and is significantly cheaper than injectable alternatives.
Novo Nordisk aims to regain market share after a difficult 2025, including profit warnings and job cuts.
Competition is intensifying with Eli Lilly, Pfizer, and nearly two dozen Chinese companies developing similar treatments.
Shares of Novo Nordisk rose over 4% after the launch but are still down 44% over the past year.
- Who
- Novo Nordisk, a Danish pharmaceutical company
- What
- Launched the world's first weight-loss pill, Wegovy
- When
- Just before Christmas 2025
- Where
- United States
- Why
- To meet demand for non-injectable weight-loss treatments and regain market share
- Company
- Novo Nordisk
- Pill Name
- Wegovy
- Price
- $149 per month (starting dose)
- Approval Date
- Just before Christmas (2025)
- Market Reaction
- Shares rose by more than 4% after launch, but down 44% over the past year
- Competitors
- Eli Lilly, Pfizer, and nearly two dozen Chinese companies
- Mechanism
- Mimics the GLP-1 hormone that reduces appetite
